Table 2 Co-medication with methotrexate or prednisone with etanercept
Methotrexate Co-Therapy Study | Patients (N = 330) |
|---|---|
Received no co-medication before or in the 12 months after ETN initiation | 222 (67%) |
Received co-medication with MTX before ETN initiation | 103 (31%) |
 Stopped MTX when ETN was initiated | 18 |
 Continued MTX for 12 months after ETN initiation | 85 |
Started MTX co-medication after ETN was initiated | 3* (2%) |
Prednisone Co-Therapy Study | Patients (N = 330) |
Received no co-medication before or in the 12 months after ETN initiation | 223 (68%) |
Received co-medication with PRD before ETN initiation | 92 (28%) |
 Stopped PRD when ETN was initiated | 46 |
 Continued PRD for 12 months after ETN initiation | 46 |
Started PRN co-medication after ETN was initiated | 15 (5%) |